Approximately 500 children are diagnosed with Acute Myeloid Leukemia
in the United States each year.
AML, also known as Acute Myelogenous Leukemia, is a cancer of the myeloid line of blood cells, characterized by the rapid growth of abnormal white blood cells that accumulate in the bone marrow and interfere with the production of normal blood cells.
AML accounts for about 20 percent of the childhood leukemias.
AML is the most common acute leukemia affecting adults, and its incidence increases with age. Although AML is a relatively rare disease, accounting for approximately 1.2% of cancer deaths in the United States, its incidence is expected to increase as the population ages.
What is Acute Myelogenous Leukemia (AML)?
AML Leukemia - Definition
Seattle Cancer Care
Acute Myelogenous Leukemia (AML)
Leukemia & Lymphoma Society
Acute Myeloid Leukemia - Understanding AML
Children's Hospital Boston - AML Leukemia
National Cancer Institute
Childhood Acute Myeloid Leukemia
St. Jude Children's Hospital
Different Types of Childhood Leukemia
Children's Cancer Fund
Understanding Childhood Cancer
National Children's Leukemia Foundation
Cancer and Leukemia